Combination metformin and liraglutide in PCOS: clinical efficacy in women and preclinical insights from gut microbiome modulation in rats
BackgroundMetformin and liraglutide have been gradually used in the treatment of polycystic ovary syndrome (PCOS) due to their metabolic benefits, but also with some adverse reactions. Evidence suggests that gut microbiota imbalance plays an important role in the pathogenesis of PCOS. This study com...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2025-11-01
|
| Series: | Frontiers in Endocrinology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1599879/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|